https://www.selleckchem.com/pr....oducts/ly3522348.htm
We found the randomized controlled trial of a brief psychological intervention targeting fear of recurrence of melanoma patients by Dieng et al. very interesting. The intervention has been shown to be effective and its implementation in the routine care of melanoma patients seems appropriate. In this regard we have developed some considerations we would like to submit to authors and readers.Background Netherton syndrome (NS) is a rare disease caused by SPINK5 mutations, featuring variable skin and hair involvement and, in many cases,
Like
Comment
Share
